HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 178481470, compound → HCID 178481340, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 178481470 | HCID 178481470 | — |
| Reactant | (1R*,2S*)-2-(3-iodo-1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-one | HCID 178517040 | — |
| Product | HCID 178481340 | HCID 178481340 | — |
Reaction Steps
The title compound was synthesized according to the method of (1R*,2S*)-2-(3-iodo-1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one, except substituting (E)-3-((3-iodo-1H-indazol-6-yl)methylene)-1-methylindolin-2-one (545 mg, 1.36 mmol) to give the title compound as a 9:1 mixture of diastereomers (405 mg, 72%); MS ESI 416.0 [M+H]+, calcd for [C18H14IN3O+H]+ 416.03.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08921545B2 |
| Source dataset | uspto-grants-2014_12 |
| ORD ID | ord-b05a049d8e2343179f9dec00d03f8dce |
| Source note | uspto-grants-2014_12 |